Apo-Amisulpride New Zealand - English - Medsafe (Medicines Safety Authority)

apo-amisulpride

apotex nz ltd - amisulpride 400mg;   - film coated tablet - 400 mg - active: amisulpride 400mg   excipient: basic butylated methacrylate copolymer isopropyl alcohol lactose monohydrate macrogol 6000 magnesium stearate   methylcellulose microcrystalline cellulose purified talc purified water sodium starch glycolate titanium dioxide - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.